Cargando…

Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease that occurs all over the world. Models of care, initially accessed from the clinical point of view, must also be evaluated in terms of their economic effectiveness, as health care systems are limited. The Integrated Care Mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandurska, Ewa, Damps-Konstańska, Iwona, Popowski, Piotr, Jędrzejczyk, Tadeusz, Janowiak, Piotr, Świętnicka, Katarzyna, Zarzeczna-Baran, Marzena, Jassem, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486702/
https://www.ncbi.nlm.nih.gov/pubmed/31002103
http://dx.doi.org/10.12659/MSM.913358
_version_ 1783414390169534464
author Bandurska, Ewa
Damps-Konstańska, Iwona
Popowski, Piotr
Jędrzejczyk, Tadeusz
Janowiak, Piotr
Świętnicka, Katarzyna
Zarzeczna-Baran, Marzena
Jassem, Ewa
author_facet Bandurska, Ewa
Damps-Konstańska, Iwona
Popowski, Piotr
Jędrzejczyk, Tadeusz
Janowiak, Piotr
Świętnicka, Katarzyna
Zarzeczna-Baran, Marzena
Jassem, Ewa
author_sort Bandurska, Ewa
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease that occurs all over the world. Models of care, initially accessed from the clinical point of view, must also be evaluated in terms of their economic effectiveness, as health care systems are limited. The Integrated Care Model (ICM) is a procedure dedicated to patients suffering from advanced COPD that offers home-oriented support from a multidisciplinary team. The main aim of the present study was to evaluate the cost-effectiveness of the ICM. MATERIAL/METHODS: We included 44 patients in the study (31 males, 13 females) with an average age 72 years (Me=71). Costs of care were estimated based on data received from public payer records and included general costs, COPD-related costs, and exacerbation-related costs. To evaluate cost-effectiveness, cost-effectiveness analysis (CEA) was used. The incremental cost-effectiveness ratio (ICER) was calculated based on changes in health care resources utilization and the value of costs observed in 2 consecutive 6-month periods before and after introducing ICM. RESULTS: Costs of care of all types decreased after introducing ICM. Demand for ambulatory visits changed significantly (p=0.037) together with a substantial decrease in the number of emergency department appointments and hospitalizations (p=0.033). ICER was more profitable for integrated care than for standard care when assessing costs of avoiding negative parameters such as hospitalizations (−227 EUR), exacerbations-related hospitalizations (−312 EUR), or emergency procedures (−119 EUR). CONCLUSIONS: ICM is a procedure that meets the criteria of cost-effectiveness. It allows for avoiding negative parameters such as unplanned hospitalizations with higher economic effectiveness than the standard type of care used in managing COPD.
format Online
Article
Text
id pubmed-6486702
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-64867022019-05-03 Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD) Bandurska, Ewa Damps-Konstańska, Iwona Popowski, Piotr Jędrzejczyk, Tadeusz Janowiak, Piotr Świętnicka, Katarzyna Zarzeczna-Baran, Marzena Jassem, Ewa Med Sci Monit Clinical Research BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common disease that occurs all over the world. Models of care, initially accessed from the clinical point of view, must also be evaluated in terms of their economic effectiveness, as health care systems are limited. The Integrated Care Model (ICM) is a procedure dedicated to patients suffering from advanced COPD that offers home-oriented support from a multidisciplinary team. The main aim of the present study was to evaluate the cost-effectiveness of the ICM. MATERIAL/METHODS: We included 44 patients in the study (31 males, 13 females) with an average age 72 years (Me=71). Costs of care were estimated based on data received from public payer records and included general costs, COPD-related costs, and exacerbation-related costs. To evaluate cost-effectiveness, cost-effectiveness analysis (CEA) was used. The incremental cost-effectiveness ratio (ICER) was calculated based on changes in health care resources utilization and the value of costs observed in 2 consecutive 6-month periods before and after introducing ICM. RESULTS: Costs of care of all types decreased after introducing ICM. Demand for ambulatory visits changed significantly (p=0.037) together with a substantial decrease in the number of emergency department appointments and hospitalizations (p=0.033). ICER was more profitable for integrated care than for standard care when assessing costs of avoiding negative parameters such as hospitalizations (−227 EUR), exacerbations-related hospitalizations (−312 EUR), or emergency procedures (−119 EUR). CONCLUSIONS: ICM is a procedure that meets the criteria of cost-effectiveness. It allows for avoiding negative parameters such as unplanned hospitalizations with higher economic effectiveness than the standard type of care used in managing COPD. International Scientific Literature, Inc. 2019-04-19 /pmc/articles/PMC6486702/ /pubmed/31002103 http://dx.doi.org/10.12659/MSM.913358 Text en © Med Sci Monit, 2019 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Clinical Research
Bandurska, Ewa
Damps-Konstańska, Iwona
Popowski, Piotr
Jędrzejczyk, Tadeusz
Janowiak, Piotr
Świętnicka, Katarzyna
Zarzeczna-Baran, Marzena
Jassem, Ewa
Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)
title Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)
title_full Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)
title_fullStr Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)
title_full_unstemmed Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)
title_short Cost-Effectiveness Analysis of Integrated Care in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD)
title_sort cost-effectiveness analysis of integrated care in management of advanced chronic obstructive pulmonary disease (copd)
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486702/
https://www.ncbi.nlm.nih.gov/pubmed/31002103
http://dx.doi.org/10.12659/MSM.913358
work_keys_str_mv AT bandurskaewa costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd
AT dampskonstanskaiwona costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd
AT popowskipiotr costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd
AT jedrzejczyktadeusz costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd
AT janowiakpiotr costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd
AT swietnickakatarzyna costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd
AT zarzecznabaranmarzena costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd
AT jassemewa costeffectivenessanalysisofintegratedcareinmanagementofadvancedchronicobstructivepulmonarydiseasecopd